Effects of neurohumoral and adrenergic agents on cyclic AMP levels in various areas of the rat brain in vitro.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D001933:Brain Stem / Q000378:metabolism; D002531:Cerebellum / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism*; D004298:Dopamine / Q000494:pharmacology*; D006624:Hippocampus / Q000378:metabolism; D006632:Histamine / Q000494:pharmacology; D007031:Hypothalamus / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D008636:Mesencephalon / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology*; D010293:Pargyline / Q000494:pharmacology*; D011453:Prostaglandins / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D012701:Serotonin / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology*; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D011453:Prostaglandins; D012701:Serotonin; D006632:Histamine; D012110:Reserpine; D010293:Pargyline; D013806:Theophylline; D000242:Cyclic AMP; D004298:Dopamine; D009638:Norepinephrine